Mark Thomas Miller,Corey Anderson,Vijayalaksmi Arumugam,Brian Richard Bear,Hayley Marie Binch,Jeremy J. Clemens,Thomas Cleveland,Erica Conroy,Timothy Richard Coon,Bryan A. Frieman,Peter Diederik Jan G
申请号：
US14876525
公开号：
US20160095858A1
申请日:
2015.10.06
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention features a compound of formula I:or a pharmaceutically acceptable salt thereof, where R1, R2, R3, W, X, Y, Z, n, o, p, and q are defined herein, for the treatment of CFTR mediated diseases, such as cystic fibrosis. The present invention also features pharmaceutical compositions, method of treating, and kits thereof.
